Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $24
Benzinga Newsdesk 11 months ago
NewsPrice TargetAnalyst Ratings
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price target from $17 to $24.
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price target from $17 to $24.